Robotic-Assisted Primary Malignant Bone Tumour Resection
60% of bone cancer patients lose limbs—robotic surgery could change that, but ortho oncology lags behind.
Approximately 60% of patients treated for primary malignant bone tumours (PMBTs) undergo amputation, owing to the size of their lesion and related local indications.[1] Hypothetically, these amputations are avoidable with improved intraoperative tumour margin evaluation and management technologies.[2] Robotic-assisted tumour resection is employed to a greater extent by other surgical disciplines; however, there has been slow and somewhat unsupported uptake in orthopaedic oncology.[3,4] In our view, orthopaedic oncology patients stand to benefit significantly from the adoption, implementation and further research of robotic-assisted PMBT resections.[4]
Click here to access the article.